GLP-1 drugs are highly effective and likely to be approved for new indications in addition to obesity and diabetes
Thymosin beta-4 does it is a defined, well-characterized endogenous protein
These data are consistent with previous studies of transgenic mice modified to express fluorescent proteins under the Glp1r promoter 47,48
Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families
Stem cell therapies may offer more comprehensive tissue regeneration capabilities through cellular replacement and differentiation, while these peptides may be simpler to administer and have fewer regulatory barriers in certain jurisdictions
The gastrointestinal effects associated with GLP-1 RAs, such as delayed gastric emptying, nausea, and vomiting, raise concerns about potential interference with the therapeutic level immunosuppressants, possibly leading to graft failure